At SkinVision, transparency and honesty is at the core of our company values. We are a for-profit company and business that aims to serve our customers through the sales and use of the SkinVision app. However, our mission and goal of saving lives through the early detection of Skin Cancer is at the heart of what we do.
So, where does your money go when you pay for a SkinVision skin check or subscription?
- Paying our dedicated and highly skilled SkinVision Dermatologists
When you conduct a Skin Check with SkinVision, your assessment is run through our SkinVision algorithm, providing 90.5% sensitivity. In addition to this, we provide a secondary level of quality assurance, which comes in the form of our specialist dermatology panel who review all high risk and low risk + symptom images.
On top of our Smart technology, these dermatologists are the real-life brains and eyes behind your recommendation and they allow us to provide you with a result that is both informed and accurate.
- Maintaining quality systems
As a CE marked and TGA approved medical device, SkinVision has to uphold strict adherence and maintenance of our quality management systems (ISO 13485), to ensure we provide you a service of high efficacy and safety. In keeping your personal and health data safe and secure, we also continue to maintain our information security management systems (ISO 27001).
To read more in detail about SkinVision’s Three ISO certifications, visit https://www.skinvision.com/news/skinvision-achieves-three-iso-certifications/.
SkinVision believes and is obligated as a medical device to implement an evidence-based approach to continuously measure the performance of the device and collect further evidence of it’s safety and effectiveness.
Thus, we invest time, energy and money to ensure that our service is clinically validated so that we can bring you, our SkinVision customers, a product that is backed by clinical evidence.
The SkinVision Service has been the object of multiple third party studies, performed by prestigious academic institutions, including Erasmus Medical Center of Rotterdam (EMC), Ludwig Maximilian University of Munich (LMU) and data published in influential journals such as the Journal of the European Academy of Dermatology and Venereology (JEADV) .
In 2022, Erasmus Medical Center (EMC) published a prospective Multicenter Diagnostic Accuracy Study further validating the performance of the SkinVision Service .
This study showed us that:
SkinVision can detect 90.5% of Skin Cancer cases. To compare: the sensitivity of general practitioners ranges between 61% and 66% [3-5]. This complements previous research on SkinVision  showing Sensitivity up to 95%.
 Udrea et al., 2019 - DOI: 10.1111/jdv.15935
 Sangers et al., 2022 - DOI: 10.1159/000520474
 Ahmadi et al., 2018 - DOI: 10.1111/jdv.14484
 Beecher et al., 2018 - DOI: 10.1007/s11845-018-1788-z
 Corbo et al., 2012 - DOI: 10.1177/120347541201600410